News & Updates

Treatment with colchicine for 6 months when commencing urate-lowering therapy (ULT) provides no additional benefit in achieving gout remission regardless of the definition used, according to a study.

Use of anifrolumab improves symptoms and induces remission in patients with refractory systemic lupus erythematosus (SLE), with an acceptable safety profile, a study has shown.

For Singaporeans with psoriatic arthritis (PsA), disabling foot pain appears to signal a more severe disease activity and exert a wide impact on daily life.